BMS-P5 structure
|
Common Name | BMS-P5 | ||
|---|---|---|---|---|
| CAS Number | 1549811-36-0 | Molecular Weight | 472.58 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C27H32N6O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BMS-P5BMS-P5 is a Novel Peptidylarginine Deiminase 4 (PAD4) Inhibitor with pIC50 values in the range of 5-7.5. BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple Myeloma. Administration of BMS-P5 to multiple myeloma-bearing mice delays appearance of symptoms and disease progression Targeting PAD4 may be beneficial for treatment of multiple myeloma. |
| Name | BMS-P5 |
|---|
| Description | BMS-P5 is a Novel Peptidylarginine Deiminase 4 (PAD4) Inhibitor with pIC50 values in the range of 5-7.5. BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple Myeloma. Administration of BMS-P5 to multiple myeloma-bearing mice delays appearance of symptoms and disease progression Targeting PAD4 may be beneficial for treatment of multiple myeloma. |
|---|
| Molecular Formula | C27H32N6O2 |
|---|---|
| Molecular Weight | 472.58 |